Synapse

← Journal of Drug Assessment

Papers in Journal of Drug Assessment

Page 1 · newest first

  1. Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviewsJournal of Drug Assessment · 2022
  2. Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in KoreaJournal of Drug Assessment · 2022
  3. A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimenJournal of Drug Assessment · 2022
  4. Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysisJournal of Drug Assessment · 2021
  5. Real-world experience of ocrelizumab in multiple sclerosis in an Arab populationJournal of Drug Assessment · 2021
  6. Efficacy and safety of timolol-dorzolamide fixed-combination three times a day versus two times a day in newly diagnosed open-angle glaucomaJournal of Drug Assessment · 2021
  7. Seizure clustersJournal of Drug Assessment · 2021
  8. Vasoactive pharmacologic therapy in cardiogenic shock: a critical reviewJournal of Drug Assessment · 2021
  9. Adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: analysis of a national specialty pharmacy databaseJournal of Drug Assessment · 2021
  10. Prevalence of Helicobacter pylori infection and the incidence of the associated malignant and peptic ulcer disease (PUD) at Nelson Mandela Academic Hospital: a retrospective analysisJournal of Drug Assessment · 2021
  11. Hereditary angioedema patients would prefer newer-generation oral prophylaxisJournal of Drug Assessment · 2020
  12. Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancerJournal of Drug Assessment · 2020
  13. A systematic evidence-based review of treatments for primary hyperhidrosisJournal of Drug Assessment · 2020
  14. Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patientsJournal of Drug Assessment · 2020
  15. The relationship between Eastern Cooperative Oncology Group performance status and healthcare resource utilization among patients with advanced or metastatic colorectal, lung or gastric cancerJournal of Drug Assessment · 2020
  16. Use of oral rivaroxaban in cerebral venous thrombosisJournal of Drug Assessment · 2020
  17. Magnitude and associated factors of medication administration error among nurses working in Amhara Region Referral Hospitals, Northwest EthiopiaJournal of Drug Assessment · 2020
  18. Efficacy and safety of PCSK9 monoclonal antibodies: an evidence-based review and updateJournal of Drug Assessment · 2020
  19. Measuring problem prescription opioid use among patients receiving long-term opioid analgesic treatment: development and evaluation of an algorithm for use in EHR and claims dataJournal of Drug Assessment · 2020
  20. Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendationsJournal of Drug Assessment · 2020
  21. Levonorgestrel emergency contraception and bodyweight: are current recommendations consistent with historic data?Journal of Drug Assessment · 2020
  22. Autologous conditioned serum: clinical and functional results using a novel disease modifying agent for the management of knee osteoarthritisJournal of Drug Assessment · 2020
  23. Does sympathetic nervous system modulate tumor progression? A narrative review of the literatureJournal of Drug Assessment · 2020
  24. The efficacy of intra-articular HYADD4-G injection in the treatment of femoroacetabular impingement: results at one year follow upJournal of Drug Assessment · 2020
  25. Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United StatesJournal of Drug Assessment · 2020
  26. Can the dexamethasone intravitreal implant Ozurdex be safely administered in an out-of-operating room setting?Journal of Drug Assessment · 2020
  27. Bioavailability of oxycodone by mouth in coronary artery bypass surgery patients – a randomized trialJournal of Drug Assessment · 2020
  28. Virtual screening for potential inhibitors of β(1,3)-D-glucan synthase as drug candidates against fungal cell wallJournal of Drug Assessment · 2020
  29. Effects ofPelargonium sidoidesextract on chemokine levels in nasal secretions of patients with non-purulent acute rhinosinusitisJournal of Drug Assessment · 2020
  30. A targeted approach to reducing rates of discontinuation and dose reduction in patients receiving sorafenib or regorafenibJournal of Drug Assessment · 2019
  31. Comparison of extended to standard half-life recombinant factor VIII therapy in patients with hemophilia A on prophylactic therapyJournal of Drug Assessment · 2019
  32. Development of a specialty pharmacy productivity benchmarking modelJournal of Drug Assessment · 2019
  33. A novel tool to monitor adherence to oral oncolytics: a pilot studyJournal of Drug Assessment · 2019
  34. Impact of outpatient specialty pharmacy on medication adherence in post-kidney transplant patientsJournal of Drug Assessment · 2019
  35. Impact of health-system specialty pharmacy services on medication adherence in pediatric patients with cystic fibrosisJournal of Drug Assessment · 2019
  36. Correlates and barriers to medication adherence in multiple sclerosis patients and their impact on clinical outcomesJournal of Drug Assessment · 2019
  37. Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnessesJournal of Drug Assessment · 2019
  38. Epidemiology of atopic dermatitis in EuropeJournal of Drug Assessment · 2019
  39. Prevalence of frailty in older people in Veneto (Italy)*Journal of Drug Assessment · 2019
  40. The burden of frailty in older people visiting GPs in Veneto and Sicily, ItalyJournal of Drug Assessment · 2019
  41. Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal womenJournal of Drug Assessment · 2019
  42. Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn’s disease or ulcerative colitisJournal of Drug Assessment · 2019
  43. Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional surveyJournal of Drug Assessment · 2019
  44. Hepatitis C virus genotype analysis in patients with chronic hepatitis in North Eastern BulgariaJournal of Drug Assessment · 2019
  45. Investigating the lowest threshold of vascular benefits from LDL cholesterol lowering with a PCSK9 mAb inhibitor (alirocumab) in healthy volunteers – a mechanistic physiological study (INTENSITY-LOW): protocol and study rationaleJournal of Drug Assessment · 2019
  46. The effect of pregabalin treatment on balance and gait in patients with chronic low back pain: a retrospective observational studyJournal of Drug Assessment · 2019
  47. ESWT and nutraceutical supplementation (Tendisulfur Forte) vs ESWT-only in the treatment of lateral epicondylitis, Achilles tendinopathy, and rotator cuff tendinopathy: a comparative studyJournal of Drug Assessment · 2019
  48. Risk factors for impulse control disorders and related behaviors in Parkinson’s disease: secondary analyses of the ICARUS studyJournal of Drug Assessment · 2019
  49. Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trialJournal of Drug Assessment · 2019
  50. The influence of SLC22A1 rs622342 and ABCC8 rs757110 genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian patients with type 2 diabetesJournal of Drug Assessment · 2019